Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the creation of compounds with neuroactive properties, including potential use in antidepressants, antipsychotics, and cognitive enhancers. The presence of both hydroxyl and trifluoroethyl groups allows for selective modifications, improving metabolic stability and blood-brain barrier penetration in drug candidates. Also explored in medicinal chemistry for designing ligands targeting neurotransmitter receptors.